Joelle Saad

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Amber B Jones, Kaysaw Tuy, Cyntanna C Hawkins, Colin H Quinn, Joelle Saad, Sam E Gary, Elizabeth Ann Beierle, Lei Ding, Kate M Rochlin, Lawrence S Lamb, Anita B Hjelmeland
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma. Cancers 16 (16) (2024)
Amber B Jones, Kaysaw Tuy, Cyntanna C Hawkins, Colin H Quinn, Joelle Saad, Sam E Gary, Elizabeth Ann Beierle, Lei Ding, Kate M Rochlin, Lawrence S Lamb, Anita B Hjelmeland
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma. Cancers 16 (16) (2024)